Vaccine Production Capacity on the Rise in China as COVID-19 Inoculations Increase
Vaccine Production Capacity on the Rise in China as COVID-19 Inoculations Increase
Attachment: A, B
BEIJING--April 12, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--The COVID-19 pandemic has sparked a sharp rise in China's vaccine production, as the country seeks to protect its citizens and export its vaccines abroad.
So far, the domestic use of China's self-produced COVID-19 vaccine has exceeded 150 million doses, and the export volume has exceeded 100 million doses. The China Vaccine Industry Association revealed that COVID-19 vaccine capacity is expected to reach 5 billion doses next year. The production is strictly controlled by the state.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects